Valence8 US LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001943819

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedBuy & Hold how tags are computed

Q2 2026 · 15 positions · Total reported value $300.49M · Top-10 concentration 92.6% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 6.7% · 0 new · 0 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +0.4% · vs SPY -1.7% · Prev Value $300.49M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +0.9% · vs SPY -1.3% · Latest Value $282.95M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, Valence8 US LP disclosed 15 equity positions with a combined reported value of $300.49M. The filing implies a focused portfolio: its ten largest positions account for 92.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Buy & Hold.

The largest disclosed positions as of Q2 2026 were QUAL ($90.42M), QQQ ($51.47M), BIL ($28.16M). By sector, the heaviest allocations are Other 100.0%.

Versus the prior quarter, Valence8 US LP opened 0 new positions, trimmed 0 and fully exited 1, a turnover rate of 6.7% of positions. The portfolio's overlap with the prior quarter was 93% of names.

The largest new positions opened in Q2 2026 were XLV ($14.82M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • XLV SELECT SECTOR SPDR TR · $14.82M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Valence8 US LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Valence8 US LP is an SEC-registered 13F filer based in Cambridge, MA, United States. As of Q2 2026 it reported 15 US equity positions with a combined value of $300.49M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: CAMBRIDGE, MA, United States
  • SEC registration: 801-122837 (status: Approved), registered 2021-12-09
  • Regulatory AUM (Form ADV): $1.87B as of 2026-03-20
  • Client mix (by RAUM): pension and profit-sharing plans 100%, pooled investment vehicles 0%
  • Manages 8 private funds, of which 4 hedge funds

Portfolio Structure

  • 15 positions · $300.49M reported value (Q2 2026)
  • Top 10 holdings = 92.6% of reported value
  • Largest position: QUAL (ISHARES MSCI USA QUALITYFACTOR ETF) at 30.1%
  • Average position size: $20.03M

Quarterly Activity

  • Q2 2026: 1 new, 6 added, 6 reduced
  • 2 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund's rebalancing suggests a shift towards growth-oriented sectors and technology, possibly reflecting a market view that favors innovation and expansion over value sectors. 2. Key Moves: - Added: - QUAL (iShares TR) - Large Cap Tech ETF (30.09% weight) - QQQ (Invesco QQQ TR) - Large Cap Growth ETF (17.13% weight) - XLP (Select Sector SPDR TR) - Consumer Staples ETF (6.40% weight) - XLV (State St HLTH CR SLCT ETF) - Health Care ETF (4.93% weight) - VTV (Vanguard Index FDS) - Total Stock Market ETF (4.89% weight) - XLV was added, indicating a new allocation to health care. - Reduced: - BIL (SPDR SERIES TRUST) - U.S. Aggregate Bond ETF (9.37% weight) - IQLT (iShares TR) - Mid Cap Tech ETF (8.70% weight) - SMH (VanEck ETF TRUST) - SemiConductor ETF (4.57% weight) - EFV (iShares TR) - MSCI Europe ETF (4.24% weight) - PWRD (TCW ETF TRUST) - Dividend Achievers ETF (2.24% weight) - The reduction in BIL suggests a shift away from fixed income, aligning with a preference for growth and equities. 3. Portfolio Structure: - Passive/Active: The portfolio is largely passive, with the majority of holdings being ETFs that track indices. - Sector Bias: The portfolio has a strong bias towards technology, growth, and health care sectors. - Risk Appetite: The increased allocation to growth and tech sectors indicates a higher risk appetite, as these sectors typically offer higher growth potential but also higher volatility. 4. Per-Holding One-Liner: - QUAL: iShares Core S&P 500 ETF (unverified) - QQQ: Invesco QQQ Trust - tracks the Nasdaq-100 index - BIL: SPDR Bloomberg Barclays Aggregate Bond ETF - tracks a broad index of U.S. investment-grade bonds - IQLT: iShares Expanded Tech-Software Sector ETF - tracks the software industry - XLP: Select Sector Consumer Staples SPDR Fund - tracks the consumer staples sector - XLV: SPDR S&P 500 Health Care ETF - tracks the health care sector - VTV: Vanguard Total Stock Market ETF - tracks the total market of U.S. stocks - SMH: VanEck Vectors Semiconductor ETF - tracks the semiconductor industry - EFV: iShares MSCI Europe ETF - tracks the MSCI Europe Index - PWRD: TCW Dividend Growth ETF - invests in companies with a strong history of dividend increases 5. One-Sentence Style Summary: The Valence8 US LP rebalanced this quarter in favor of growth-oriented sectors like technology and health care, increasing its exposure to riskier asset classes and reducing its bond allocation.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Other 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 412.06K $90.42M 30.09%
30.09%
Add
2 69.89K $51.47M 17.13%
17.13%
Add
3 307.31K $28.16M 9.37%
9.37%
Reduce
4 527.43K $26.13M 8.70%
8.70%
Reduce
5 231.63K $19.24M 6.40%
6.40%
Add
6 93.38K $14.82M 4.93%
4.93%
New
7 67.42K $14.69M 4.89%
4.89%
Add
8 20.93K $13.73M 4.57%
4.57%
Reduce
9 166.32K $12.73M 4.24%
4.24%
Reduce
10 54.69K $6.73M 2.24%
2.24%
Reduce
11 138.17K $6.26M 2.08%
2.08%
Add
12 121.28K $5.60M 1.86%
1.86%
Add
13 61.24K $4.62M 1.54%
1.54%
Hold
14 15.07K $3.04M 1.01%
1.01%
Reduce
15 37.02K $2.85M 0.95%
0.95%
Hold

FAQ

What did Valence8 US LP buy in 2026-Q2?

In its 2026-Q2 13F filing, Valence8 US LP reported 15 equity positions worth $300.49M in aggregate; its largest disclosed positions were QUAL ($90.42M), QQQ ($51.47M), BIL ($28.16M).

How large is Valence8 US LP's portfolio?

Valence8 US LP reported $300.49M of long equity holdings across 15 positions as of 2026-Q2. Top-10 holdings account for 92.6% of reported value.

What is Valence8 US LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/valence8-us/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →